The tyrosine kinase Abl-related gene ARG is fused to ETV6 in an AML-M4Eo patient with a t(1;12)(q25;p13): Molecular cloning of both reciprocal transcripts

Blood

Volumn 94, Issue 12, 1999, Pages 4370-4373

  Cazzaniga, Giovanni ^a   Tosi, Sabrina ^b   Aloisi, Alessandra ^b   Giudici, Giovanni ^b   Daniotti, Maria ^b   Pioltelli, Pietro ^b   Kearney, Lyndal ^b   Biondi, Andrea ^b  

^a SAN GERARDO HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; CHROMOSOME 12P; CYTOGENETICS; EOSINOPHILIA; FEMALE; GENE FUSION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION;

EID: 0032778537     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.12.4370.424k34_4370_4373     Document Type: Article

References (24)

1. Mitelman F (ed): Catalog of Chromosome Aberrations in Cancer (ed 5). New York, NY, Liss, 1994
2. Golub TR, Barker GF, Lovett M, Gilliland DG: Fusion of PDGF receptor to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307, 1994
3. Raimondi SC, Shurtleff SA, Downing JR, Rubnitz, J, Mathew S, Hancock M, Pui CH, Rivera GK, Grosveld GC, Behm FG: 12p abnormalities and the TEL gene (ETV6) in childhood acute lymphoblastic leukemia. Blood 90:4559, 1997
4. Tosi S, Giudici G, Mosna G, Harbott J, Specchia G, Grosveld G, Privitera E, Kearney L, Biondi A, Cazzaniga G: Identification of new partner chromosomes involved in fusions with the ETV6 (TEL) gene in hematologic malignancies. Genes Chromosomes Cancer 21:223, 1998.
5. Rubnitz JE, Pui C-H, Downing JR: The role of TEL fusion genes in pediatric leukemias. Leukemia 13:6, 1999
6. Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM: The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res 55:34, 1995
7. Peeters P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P, Monpoux F, Van Rompaey L, Baens M, Van den Berghe H, Marynen P: Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood 90:2535, 1997
8. Lacronique V, Boureux A, Valle VD, Poirel H, Quang CT, Mauchauffe M, Berthou C, Lessard M, Berger R, Ghysdael J, Bernard OA: A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 278:1309, 1997
9. Eguchi M, Eguchi-Ishimae M, Tojo A, Morishita K, Suzuki K, Sato Y, Kudoh S, Tanaka K, Setoyama M, Nagamura F, Asano S, Kamada N: Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). Blood 93:1355, 1999
10. Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH: A novel E7V6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 18:184, 1998
11. Golub TR, Goga A, Barker GF, Afar DE, McLaughlin J, Bohlander SK, Rowley JD, Witte ON, Gilliland DG: Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol Cell Biol 16:4107, 1996
12. Andreasson P, Johansson B, Carlsson M, Jarlsfelt I, Fioretos T, Mitelman F, Hoglund M: BCR/ABL-negative chronic myeloid leukemia with ETV6/ABL fusion. Genes Chromosomes Cancer 20:299, 1997
13. Van Dongen JJM, Macintyre EA, Gilbert J, Delabesse E, Rossi V, Saglio G, Gottardi E, Rambaldi A, Dotti P, Griesinger F, Parreira A, Gameiro P, Gonzalez Diaz M, Malec M, Langerak AW, San Miguel JF, Biondi A: Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia. Leukemia (in press)
14. Baens M, Peeters P, Guo C, Aerssens J, Marynen P: Genomic organization of TEL: The human ETS-variant gene 6. Genome Res 6:404, 1996
15. Langabeer SE, Walker H, Gale RF, Wheatley K, Burnett AK, Goldstone AH, Linch DC: Frequency of CBFb/MYHII fusion transcript in patients entered into the U.K. MRC AML trials. The MRC Adult Leukemia Working Party. Br J Haematol 96:736, 1997
16. Kruh GD, King CR, Kraus MH, Popescu NC, Amsbaugh SC, McBride WO, Aaronson SA: A novel human gene closely related to the abl proto-oncogene. Science 234:1545, 1986
17. Kruh GD, Perego R, Miki T, Aaronson SA: The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases. Proc Natl Acad Sci USA 87:5802, 1990
18. Wang B. Kruh GD: Subcellular localization of the Arg protein tyrosine kinase. Oncogene 13:193, 1996
19. Sawyers CL: Chronic myeloid leukemia. N Engl J Med 340: 1330, 1999
20. Mysliwiec T, Perego R, Kruh GD: Analysis of chimeric Gag-Arg/ AhI molecules indicates a distinct negative regulatory role for the Arg C-terminal domain. Oncogene 12:631, 1996
21. Carroll M, Tomasson MH, Barker GF, Golub TR, Gilliland DG: The TEL platelet-derived growth factor receptor (PDGFR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFR kinase-dependent signaling pathways. Proc Natl Acad Sci USA 93:14845, 1996
22. Golub TR, Goga A, Barker GF, Afar DE, McLaughlin J, Bohlander SK, Rowley JD, Witte ON, Gilliland DG: Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol Cell Biol 16:4107, 1996
23. Okuda K, Golub TR, Gilliland DG, Griffin JD: p210BCR/ABL, p190BCR/ABL and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines. Oncogene 13:1147, 1996
24. Hannemann JR, McManus DM, Kabarowsky JH, Wiedemann LM: Haemopoietic transformation by the TEL/ABI. oncogene. Br J Haematol 102:475, 1998